- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 241/40 - Benzopyrazines
Patent holdings for IPC class C07D 241/40
Total number of patents in this class: 67
10-year publication summary
|
5
|
1
|
7
|
6
|
4
|
8
|
1
|
6
|
4
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1595 |
9 |
| Intra-Cellular Therapies, Inc. | 411 |
5 |
| Astex Therapeutics Limited | 236 |
3 |
| Development Center for Biotechnology | 135 |
3 |
| Platefuse, Inc. | 8 |
3 |
| Boehringer Ingelheim International GmbH | 4648 |
2 |
| Amgen Inc. | 4044 |
2 |
| Board of Regents, The University of Texas System | 5803 |
2 |
| Georgia Tech Research Corporation | 2736 |
2 |
| BP Oil International Limited | 77 |
2 |
| Sunovion Pharmaceuticals Inc. | 267 |
2 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3156 |
2 |
| Duke Street Bio Limited | 13 |
2 |
| F. Hoffmann-La Roche AG | 7921 |
1 |
| Roche Diagnostics GmbH | 2695 |
1 |
| Roche Diagnostics Operations, Inc. | 1488 |
1 |
| FUJIFILM Corporation | 29399 |
1 |
| Semiconductor Energy Laboratory Co., Ltd. | 11416 |
1 |
| Cheil Industries Inc. | 855 |
1 |
| Ambrx, Inc. | 183 |
1 |
| Other owners | 21 |